The double edged interferon riddle in COVID-19 pathogenesis.
作者信息
Gupta Rahul
机构信息
, Kolkata, India.
出版信息
Crit Care. 2020 Nov 1;24(1):631. doi: 10.1186/s13054-020-03337-z.
Abstract
摘要
相似文献
1
The double edged interferon riddle in COVID-19 pathogenesis.
Crit Care. 2020 Nov 1;24(1):631. doi: 10.1186/s13054-020-03337-z.
2
Interferon beta-1a for COVID-19: critical importance of the administration route.
Crit Care. 2020 Jun 12;24(1):335. doi: 10.1186/s13054-020-03048-5.
3
Interferon deficiency can lead to severe COVID.
Nature. 2020 Nov;587(7834):374-376. doi: 10.1038/d41586-020-03070-1.
4
Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
J Infect Dis. 2020 Sep 14;222(8):1413. doi: 10.1093/infdis/jiaa454.
5
JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword.
Int Arch Allergy Immunol. 2020;181(7):563-564. doi: 10.1159/000508750. Epub 2020 May 26.
6
COVID-19 and Racism-a double edged dagger.
Lancet Diabetes Endocrinol. 2020 Aug;8(8):649. doi: 10.1016/S2213-8587(20)30243-6. Epub 2020 Jul 10.
7
COVID-19 poses a riddle for the immune system.
Nature. 2020 Aug;584(7821):345-346. doi: 10.1038/d41586-020-02379-1.
8
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
J Infect Dis. 2020 Aug 4;222(5):722-725. doi: 10.1093/infdis/jiaa350.
9
Low dose radiation therapy for COVID-19 pneumonia: A double-edged sword.
Radiother Oncol. 2020 Jun;147:224-225. doi: 10.1016/j.radonc.2020.04.026. Epub 2020 Apr 20.
10
Response to: Low dose radiation therapy for COVID-19 pneumonia a double-edged sword.
Radiother Oncol. 2020 Jun;147:226. doi: 10.1016/j.radonc.2020.04.042. Epub 2020 May 7.
引用本文的文献
1
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
Biomedicines. 2022 Oct 19;10(10):2628. doi: 10.3390/biomedicines10102628.
2
Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
Bull Natl Res Cent. 2022;46(1):100. doi: 10.1186/s42269-022-00781-5. Epub 2022 Apr 13.
3
The role of type I interferon in the treatment of COVID-19.
J Med Virol. 2022 Jan;94(1):63-81. doi: 10.1002/jmv.27317. Epub 2021 Sep 17.
本文引用的文献
1
The type I interferon response in COVID-19: implications for treatment.
Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.
2
Interferon beta-1a for COVID-19: critical importance of the administration route.
Crit Care. 2020 Jun 12;24(1):335. doi: 10.1186/s13054-020-03048-5.
3
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2. doi: 10.1016/j.chom.2020.04.017. Epub 2020 May 4.
4
Neutrophil extracellular traps in COVID-19.
JCI Insight. 2020 Jun 4;5(11):138999. doi: 10.1172/jci.insight.138999.
5
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.
J Clin Invest. 2009 Jul;119(7):1910-20. doi: 10.1172/JCI35412.
Zotero 插件